Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Mylan, Purepac and ESI Lederle report FDA generic approvals

July 14, 1997

Beneficial cardiovascular effects of garlic demonstrated in humans

July 14, 1997

CMV infection implicated in atherosclerosis

July 14, 1997

ETA receptor blockade for counteracting effects of angiotensin II

July 11, 1997

n-3 fatty acids for prevention of restenosis

July 11, 1997

Magnesium implicated in death from cardiovascular disease

July 11, 1997

TEI-A0225: new treatment for restenosis

July 11, 1997

Cardiovascular effects of psychotropic drugs

July 11, 1997

Chugai reports sydnonimine derivatives for angina

July 11, 1997

CPC-111 moves toward pivotal trials for bypass surgery

July 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...